Clinical Trial Update: Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating rituximab in patients with newly diagnosed stage II, stage III, or stage IV follicular lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: University College, London | Conditions: Lymphoma | Phase 3 | Status: COMPLETED